ATE531362T1 - Verfahren zur verminderung oder linderung von entzündungen im verdauungstrakt - Google Patents

Verfahren zur verminderung oder linderung von entzündungen im verdauungstrakt

Info

Publication number
ATE531362T1
ATE531362T1 AT07814746T AT07814746T ATE531362T1 AT E531362 T1 ATE531362 T1 AT E531362T1 AT 07814746 T AT07814746 T AT 07814746T AT 07814746 T AT07814746 T AT 07814746T AT E531362 T1 ATE531362 T1 AT E531362T1
Authority
AT
Austria
Prior art keywords
reducing
digestive tract
relieving inflammation
subject
inflammation
Prior art date
Application number
AT07814746T
Other languages
German (de)
English (en)
Inventor
Louis Tartaglia
Thomas Barnes
Robert Coopersmith
Scott Malstrom
David White
Dominic Picarella
Original Assignee
Ore Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ore Pharmaceuticals Inc filed Critical Ore Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE531362T1 publication Critical patent/ATE531362T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT07814746T 2006-09-08 2007-09-07 Verfahren zur verminderung oder linderung von entzündungen im verdauungstrakt ATE531362T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82507506P 2006-09-08 2006-09-08
US82780706P 2006-10-02 2006-10-02
PCT/US2007/077857 WO2008031014A1 (en) 2006-09-08 2007-09-07 Method for reducing or alleviating inflammation in the digestive tract

Publications (1)

Publication Number Publication Date
ATE531362T1 true ATE531362T1 (de) 2011-11-15

Family

ID=38670723

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07814746T ATE531362T1 (de) 2006-09-08 2007-09-07 Verfahren zur verminderung oder linderung von entzündungen im verdauungstrakt

Country Status (11)

Country Link
US (1) US20080234345A1 (enExample)
EP (1) EP2059234B1 (enExample)
JP (1) JP2010502736A (enExample)
CN (1) CN101568331A (enExample)
AT (1) ATE531362T1 (enExample)
AU (1) AU2007292247A1 (enExample)
CA (1) CA2662535A1 (enExample)
DK (1) DK2059234T3 (enExample)
ES (1) ES2376493T3 (enExample)
IL (1) IL197362A0 (enExample)
WO (1) WO2008031014A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
JP2011513491A (ja) * 2008-03-10 2011-04-28 オレ・ファーマシューティカルズ・インコーポレーテッド 近位消化管の障害の治療
US20100204286A1 (en) * 2009-02-12 2010-08-12 Donahue Stephen R Method for reducing gastrointestinal adverse effects of cytotoxic agents
JP5845171B2 (ja) * 2010-03-04 2016-01-20 大日本住友製薬株式会社 炎症性腸疾患用薬剤
ES2742195T3 (es) 2010-03-12 2020-02-13 Omeros Corp Inhibidores de PDE10 y composiciones y métodos relacionados
NZ716494A (en) 2014-04-28 2017-07-28 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
NZ716462A (en) 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
MA41271A (fr) * 2014-12-26 2017-10-31 Celgene Alpine Invest Company Ii Llc Méthodes d'utilisation d'oligonucléotides antisens ciblant smad7
AU2016250843A1 (en) 2015-04-24 2017-10-12 Omeros Corporation PDE10 inhibitors and related compositions and methods
WO2017079678A1 (en) 2015-11-04 2017-05-11 Omeros Corporation Solid state forms of a pde10 inhibitor
GB202116266D0 (en) * 2021-11-11 2021-12-29 Bicycletx Ltd Novel use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194556B1 (en) * 1997-12-11 2001-02-27 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor
US7045532B2 (en) 1999-04-30 2006-05-16 Millennium Pharmaceuticals, Inc. ACE-2 modulating compounds and methods of use thereof
IL146000A0 (en) * 1999-04-30 2002-07-25 Millennium Pharm Inc Ace-2 inhibiting compounds and methods of use thereof
US6900033B2 (en) * 2001-06-04 2005-05-31 Human Genome Sciences, Inc. Methods and compositions for modulating ACE-2 activity
GB0203061D0 (en) 2002-02-08 2002-03-27 Novartis Ag Organic compounds
CA2509526A1 (en) * 2002-09-24 2004-04-15 Combinatorx, Incorporated Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
TW200509958A (en) * 2003-02-14 2005-03-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050203168A1 (en) * 2004-03-11 2005-09-15 The Regents Of The University Of Michigan Angiotensin converting enzyme inhibitor use for treatment and prevention of gastrointestinal disorders
WO2008031013A1 (en) * 2006-09-08 2008-03-13 Gene Logic Inc. Method for treating inflammatory diseases of the digestive tract

Also Published As

Publication number Publication date
ES2376493T3 (es) 2012-03-14
IL197362A0 (en) 2009-12-24
US20080234345A1 (en) 2008-09-25
WO2008031014A1 (en) 2008-03-13
DK2059234T3 (da) 2011-11-28
EP2059234B1 (en) 2011-11-02
AU2007292247A1 (en) 2008-03-13
EP2059234A1 (en) 2009-05-20
JP2010502736A (ja) 2010-01-28
AU2007292247A2 (en) 2009-03-26
CA2662535A1 (en) 2008-03-13
CN101568331A (zh) 2009-10-28

Similar Documents

Publication Publication Date Title
ATE531362T1 (de) Verfahren zur verminderung oder linderung von entzündungen im verdauungstrakt
WO2014144650A3 (en) Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
MX366925B (es) Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
MX382960B (es) Inhibidores de la recirculación de ácidos biliares para el tratamiento de hipercolemia y enfermedad hepática colestásica.
WO2012142498A3 (en) Mif inhibitors and their uses
EA201101568A1 (ru) Лечение ex vivo иммунологических нарушений с помощью ингибиторов pkc-teta
EP2490583A4 (en) TREATMENT OF STRESS-RELATED HARNINE INCONTINENCE IN WOMEN
WO2010068794A3 (en) Hif inhibitors and use thereof
WO2009079451A3 (en) Compositions and methods of promoting wound healing
EP2671891A3 (en) Ang-2 inhibition to treat multiple sclerosis
EA201001496A1 (ru) Ингибиторы гранулоцитарно-макрофагального колониестимулирующего фактора (gm-csf) и интерлейкина-17 (il-17) для терапии
WO2010062900A3 (en) A new family of pain producing substances and methods to produce novel analgesic drugs
MX2009011749A (es) Compuestos triciclicos como inhibidores de metaloproteinasa matricial.
CA2837895C (en) Methods of treating or preventing neurological diseases
MX390196B (es) Metodo para fabricar una composicion que comprende un anestesico local, un heparinoide y un regulador de ph.
NZ593019A (en) Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage
MX2011004870A (es) Composicion de combinacion que comprende un inhibidor de dhodh y metotrexato para tratar enfermedades autoinmunes.
WO2008039327A3 (en) Method of treatment using fatty acid synthesis inhibitors
WO2007147868A3 (en) Prevention of muscle atrophy
WO2011159655A3 (en) IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
TW200738247A (en) Method and composition for treating allergic diseases
WO2007097980A3 (en) Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
WO2011038924A3 (en) Proteasome inhibitors for treating cancer
WO2007149543A3 (en) Scar treatment using protein phosphatase inhibitors
MX2010013790A (es) Composiciones y metodos para tratar inflamacion de corneas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2059234

Country of ref document: EP